Stanford-led benchmark ranks AI models for brain tumor MRI segmentation
Five top AI models compared head-to-head on glioma and meningioma tumor detection from MRI scans...
A new unified benchmark evaluates five state-of-the-art 3D deep learning models—3D U-Net, SegResNet, Swin UNETR, SegMamba, and SegMambaV2—for brain tumor segmentation from MRI. The models span CNN, Transformer, and State Space Model architectures and are tested under identical preprocessing, augmentation, training, and evaluation conditions across two distinct clinical datasets: meningioma (BraTS 2023) and post-treatment glioma (BraTS 2024). By measuring both segmentation accuracy and computational costs like inference time and model size, the study highlights real trade-offs between performance and efficiency, offering practical guidance for challenging 3D brain tumor segmentation tasks.
- First standardized benchmark comparing 5 leading 3D medical imaging models (3D U-Net, SegMambaV2, Swin UNETR, SegResNet) under identical conditions
- Evaluated on BraTS 2023 (meningioma) and BraTS 2024 (post-treatment glioma) datasets with standardized preprocessing
- Results quantify trade-offs between segmentation accuracy (Dice scores), inference time, and model size across CNN, Transformer, and State Space Model architectures
Why It Matters
Enables faster, more reliable clinical decision-making in neuro-oncology by providing evidence-based AI model selection for tumor segmentation